Biotechnology company committed to healthier humans and ecosystems. We research, innovate and develop novel industry solutions with fungi.
KÄÄPÄ Biotech has raised $10.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
KÄÄPÄ Biotech's investors include PeakBridge, Zintinus.
KÄÄPÄ Biotech is headquartered in Karjalohja, Finland.
Biotechnology company committed to healthier humans and ecosystems. We research, innovate and develop novel industry solutions with fungi.
KÄÄPÄ Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KÄÄPÄ Biotech — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/kp-biotech. Accessed September 28, 2026.
VCBacked. (2025). KÄÄPÄ Biotech — Funding & Investors. Retrieved September 28, 2026, from https://www.vcbacked.co/company/kp-biotech
{{cite web |title=KÄÄPÄ Biotech — Funding & Investors |url=https://www.vcbacked.co/company/kp-biotech |website=VCBacked |access-date=September 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated